Navigation Links
GlaxoSmithKline to Acquire Sirtris Pharmaceuticals, a World Leader in 'Sirtuin' Research and Development
Date:4/22/2008

LONDON, PHILADELPHIA AND CAMBRIDGE, Mass., April 22 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) and Sirtris Pharmaceuticals Incorporated (Nasdaq: SIRT) announced today that they have entered into a definitive agreement pursuant to which GlaxoSmithKline will acquire Sirtris Pharmaceuticals for approximately USD720 million (or approx. GBP362 million) through a cash tender offer of USD22.50 (or approx. GBP11.33) per share.

Through the acquisition of Sirtris, GSK will significantly enhance its metabolic, neurology, immunology and inflammation research efforts by establishing a presence in the field of sirtuins, a recently discovered class of enzymes that are believed to be involved in the ageing process. Sirtris Pharmaceuticals has established a drug discovery capability to exploit sirtuin modulation for the treatment of human disease, an approach that has the potential to generate multiple clinically and commercially important products. Their focus to date has been on the development of SIRT1 activators for the treatment of Type 2 Diabetes Mellitus (T2DM).

"Modulation of this family of enzymes is a potentially transformative science that could address diseases associated with metabolism and ageing such as diabetes, muscle wasting, and neurodegeneration," commented Moncef Slaoui, Chairman GSK R&D. "This acquisition continues GSK's strategy of pursuing the best new science, externally or internally, to bring new medicines to patients and value to the GSK pipeline. Our intent is to retain all Sirtris
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
2. AUDIO from Medialink and GlaxoSmithKline: Fiber Key in Managing Irritable Bowel Syndrome (IBS) Symptoms
3. Exelixis Submits XL880 Diligence Report to GlaxoSmithKline
4. GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program
5. GlaxoSmithKline and Anacor Pharmaceuticals Form Alliance to Develop Systemic Antivirals and Antibiotics Based on Boron Chemistry
6. BioWa Announces Licensing of BioWas POTELLIGENT(R) Technology by GlaxoSmithkline for Use in Antibody Research and Development
7. GlaxoSmithKline Consumer Healthcare Recommends Maintaining FDAS Current Two-Class Drug System
8. GlaxoSmithKline Responds to JAMA Article on the ICES Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes
9. GlaxoSmithKline Announces Data on TYKERB(R) (Lapatinib) Plus Capecitabine for the Treatment of HER2 Positive Breast Cancer Brain Metastases
10. Vaccinex Antibody Licensed to GlaxoSmithKline
11. Ingenuity Systems Extends Enterprise-Level Software Agreement With GlaxoSmithKline

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Health care employment grew by 29,000 jo...to show consistent growth during the U.S. recessio... in trouble, and health systems are coming closer ...ad of just administrators. , ...yment continued growing in October despite the she...
(Date:11/24/2009)...ov.24/PRNewswire-Asia/--NODPharmaceuticalsInc.anno...edthepatentapplicationfor,itsnano-particleoraldeli...efficientapproachtoincorporatepeptidesor,proteinsi...fdrugs,otherwiseadministeredasinjections.NODtechno...cromoleculardrugssuchasinsulin,interferon,growthh...
(Date:11/24/2009)...ov.24/PRNewswire-Asia/--ShanghaiBiolaxyannouncedth...approvedthe,investigationalnewdrugapplication(IND)...linformulationtotreatdiabetes.ThisIND,approvalallo..., Diabetesisadisordercharacteristicofhighbloodg...softenresultinseveremicro-and,macro-vasculardiseas...
(Date:11/24/2009)... The FBI recently approved the Promega Powe...pating in or generating DNA records for the Nation...dison, WI USA (PRWEB) -- The FBI recently approved... by laboratories participating in, or generating D...S). NDIS currently contains more than seven millio...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2
...N -- (April 29, 2009) -- Spanish and U.S. physicis...eally does matter when it comes to predicting the ...atom wide. , In new research appearing this week ...versity of Alicante and at Rice University in Hous...erromagnetic metals like iron, cobalt and nickel b...
...SPRING, Md., April 29 United Therapeutics Corpora...ment of Mr. Richard Giltner to its Board of Direct...has over twenty years of experience in the financi...tional financial markets, financial derivatives, a...r to beginning a one-year sabbatical on October 15...
... Breakthrough technology could tr... Indianapolis (PRWEB) April 29, 2009 - Sc...ubsidiary of The Dow Chemical Company (NYSE:DOW), ...ide-tolerant trait to a specific, pre-determined l...e modification is practical and feasible, accordin...
Other Biology Technology:Nanophysicists find unexpected magnetic effect 2Richard Giltner Joins United Therapeutics Board of Directors 2Dow AgroSciences Confirms Efficacy of Zinc Finger Nucleases for Precise Genome Modification in Maize 2Dow AgroSciences Confirms Efficacy of Zinc Finger Nucleases for Precise Genome Modification in Maize 3
(Date:11/24/2009)... a remarkable class of ring-shaped protein motors ...e Berkeley National Laboratory (Berkeley Lab) usin...ine at the Advanced Light Source (ALS). These prot...nd replication, and are vital to the survival of a... such as the human papillomavirus, which has been ...
(Date:11/24/2009)...d is a matter of debate. A high-profile study a fe...ent of their carbon from trees and leaves, evidenc...d aquatic ecosystems. , But new research from th...y to be true. Algae provide a much richer diet for...h published this week in the Proceedings of the N...
(Date:11/23/2009)...unity-associated strain of the deadly superbug MRS...ommon antibioticsposes a far greater health threat...hospitals, according to a study in the December is...w threat is easily picked up in fitness centers, s...the overall burden of MRSA within hospitals, the r...
Breaking Biology News(10 mins):Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3New study finds MRSA on the rise in hospital outpatients 2Leading for Growth in the New Economic Reality Includes Vision and Innovation 12654 1Leading for Growth in the New Economic Reality Includes Vision and Innovation 12654 2Leading for Growth in the New Economic Reality Includes Vision and Innovation 12654 3Oral and Maxillofacial Surgeons Applaud Senator Mary Landrieu 28D LA 29 For Introducing Legislation to Require Insurance Coverage for Children With C 49078 1Oral and Maxillofacial Surgeons Applaud Senator Mary Landrieu 28D LA 29 For Introducing Legislation to Require Insurance Coverage for Children With C 49078 2Premiere Fibers Unveils New Logo Names for Innovative Brands 49074 1Premiere Fibers Unveils New Logo Names for Innovative Brands 49074 2
...ans suffer a skin disorder called vitiligo, which ...and other parts of the body. , A Loyola Universit...llion federal grant to investigate a new way to tr...ay to new treatments for melanoma, the deadliest f...uto-immune disease, in which the immune system goe...
...ase inhibitors to treat breast cancer or prevent i...g a soy-based dietary supplement, researchers repo... effects of estrogen in the body, can negate the e...signed to reduce the levels of estrogens that can ...r. , The new study, which included researchers fr...
... investigators at the Department of Surgery at Jef...ity and the Kimmel Cancer Center at Jefferson, has...r cells by using nanoparticles to successfully del... set to be published in the October issue of Can...s unique strategy has been tested in pancreatic ca...
Other Biology News:Vitiligo skin disorder could yield clues in fight against melanoma 2The dietary supplement genistein can undermine breast cancer treatment 2The dietary supplement genistein can undermine breast cancer treatment 3Jefferson scientists deliver toxic genes to effectively kill pancreatic cancer cells 2Jefferson scientists deliver toxic genes to effectively kill pancreatic cancer cells 3
...lenow) Fragment, Exonuclease Minus, is a DNA-depen...594;3´ and the 3´→5´ exonucle...erase I (1,2). It is used for random primer labeli...(5). Klenow Fragment, Exonuclease Minus, will leav...
Goat Anti-Human SMVT (N-14) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Combiplate 8 from Thermo Scientific
...oxycytidine Dideoxycytidine is a cytidine analog ...retroviral activity. Immunogen: Chemical / Smal...specificity of the ddC antiserum was determined by...s of ddC analog at the 50% intercept of the respec...
Biology Products: